This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year and boy did they deliver.
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year and boy did they deliver. Let us know on social media.
Welcome to our Healthcare IT Today Weekly Roundup. Each week, well be providing a look back at the articles we posted and why theyre important to the healthcare IT community. Read more… 2025 Health IT Predictions: Pharma. We have plenty more predictions from the Healthcare IT Today community. Happy 2025!
Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drugdevelopment. Petra Jantzer, Ph.D.,
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes.
New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.
This is the pathway toward achieving human digital twins, dynamic models that not only reflect and allow health monitoring but also enhance patient stratification, improve the success rates of drugdevelopment programs, and enable treatment testing before application.
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drugdevelopment and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
The companies are evolving in many ways, including stepping outside drugdevelopment to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
In this video, he describes other ways that AI can make drugdevelopment more efficient. At the design stage, a drug company can run millions of simulations to determine where risks lie and what parameters are most promising. Pryluk also discusses equity and explainability. Watch the video for more insights.
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes.
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
He also said that the benefits go beyond doctors; for instance, care coordinators can be more efficient and AI can help drugdevelopment. Learn more about UST: [link] Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT. Tell us what you think.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
That doesn’t just lead to faster trials, it changes the way companies can think about drugdevelopment going from waterfall big bets to agile research.” . “We’re fixing that with a new paradigm for running trials underpinned by technology.
As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drugdevelopment and diagnostics.
Focus on Digital Health and AI: European companies will invest in digital health startups and AI-driven solutions to improve patient outcomes and operational efficiency. Consolidation in Specific Segments: M&A activity will be concentrated in areas like telemedicine, medical devices, and health IT. Subscribe Today!
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. Provider search and scheduling software maker Kyruus will acquire Epion Health , a digital patient engagement tool.
Digital transformation is the topic du jour in healthcare today. Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. Healthcare IT News is a HIMSS Media publication.
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut DrugDevelopment Timelines and Costs, Transforming Cancer and Rare Disease Treatments Company Raises $24.6
About AllStripes Founded in 2017, AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. Originally announced October 23rd, 2023
“We are excited to announce this funding that supports our mission to enhance the drugdevelopment pathway from discovery through commercialization,” said Eran Seger, Co-Founder and CEO at Protai. “I We look forward to scaling our organization and its important work towards revolutionizing the drugdevelopment landscape.” “Our
This ML-driven adaptive process can significantly accelerate the clinical drugdevelopment process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.
.” “The massive proliferation of patient data, coupled with advances in analytical methods, can enable providers and pharmaceutical companies to transform clinical decision-making, optimize drugdevelopment, and ultimately improve patient outcomes,” said Tyler Schinto from Presidio Ventures.
.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
Redi.Health recently forged partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp DrugDevelopment Patient Access Solutions with Redi.Health’s digital support platform to more seamlessly connect patients and providers. .
We are particularly excited about the ability of these tools to drive more efficient and faster drugdevelopment processes in the biopharma industry.” “The “We believe Flywheel’s unique software solutions enable the smarter use and interpretation of the vast amounts of information associated with large numbers of medical imaging scans.
“Data quality has become one of the biggest problems in the healthcare industry – one that has significant consequences,” said Cornerstone Co-founder and CEO Michael Elashoff. Poor quality data leads to drugdevelopment being delayed, patients being misdiagnosed and inaccurate scientific conclusions.
Hospitals across the nation are using connected health and RPM to great effect during the pandemic. To help healthcare CIOs, CMOs and other leaders find connected health devices and RPM technologies, Healthcare IT News has compiled this comprehensive listing of vendors. Healthcare IT News is a HIMSS Media publication.
Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk
Animal Health investments focus on disruptive technologies that have a meaningful impact on global animal health and animal agriculture. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic DrugDevelopment. For more information, visit www.mtngp.com. About SeedtoB.
It will become part of Fujifilm’s Synapse Enterprise Imaging portfolio – an award-winning suite of healthcare IT solutions that unify imaging, data access and workflows across the health system. According to a recent DeciBio article, Dynamyx is shown to have one of the largest partnership networks in the digital pathology space.
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year and boy did they deliver. Let us know on social media.
As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Do they have the right patients enrolled who are most likely to respond?
In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drugdevelopment processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery. Tell us what you think.
This contextual understanding is pivotal in drugdevelopment decision-making, revealing patient selection insights unpredictable using today’s tools to maximize the value of both approved medicines and drugs in development.” .
Here they are producing more accurate and efficient tools for drugdevelopment. The biotherapeutics monitoring equipment from 908 Devices illustrates the positive role technology—sensitive measuring devices, analytics, and automation—can play in medicine.
From 3D-printed limbs to surgical robots , health providers have implemented AI to find creative treatment solutions for complex medical issues. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drugdevelopment.
The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drugdevelopment in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.
So as 2025 begins, let’s all strive to reduce disparities and promote health equity in underserved communities this year! Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drugdevelopment and discovery process.
Welcome to the inaugural edition of Healthcare IT Today Bonus Features. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job. .”
This umbrella term incorporates a diverse range of products ranging from over the counter consumer devices for health monitoring (e.g. Healthtech is a broad term that encompasses the use of technology to improve healthcare. Drug discovery: AI-powered tools will accelerate the drugdevelopment process by analyzing vast datasets.
We need to start searching for how we can use technology , new or old, to fix health inequality and discrimination. We reached out to our beautiful Healthcare IT Today Community to get their insights on the role technology can play in working towards health equity. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content